Veeva Systems Inc.
$165.91
▼
-1.12%
2026-04-22 10:12:13
www.veeva.com
NYQ: VEEV
Explore Veeva Systems Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$27.21 B
Current Price
$165.91
52W High / Low
$310.5 / $148.05
Stock P/E
30.52
Book Value
$44.05
Dividend Yield
—
ROCE
12.48%
ROE
13.93%
Face Value
—
EPS
$5.44
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
7,928
Beta
1.1
Debt / Equity
1.33
Current Ratio
4.88
Quick Ratio
4.89
Forward P/E
15.32
Price / Sales
7.79
Enterprise Value
$18.27 B
EV / EBITDA
18.55
EV / Revenue
5.72
Rating
Buy
Target Price
$266.97
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | SOPHiA GENETICS SA | $5.19 | — | $371.96 M | — | -63.03% | -1.1% | $5.7 / $2.58 | $0.69 |
| 2. | OneMedNet Corporation | $0.94 | — | $46.93 M | — | 361.52% | 29.62% | $4.22 / $0.3 | $-0.06 |
| 3. | Evolent Health, Inc. | $2.93 | — | $327.1 M | — | -1.31% | -66.54% | $12.06 / $2.1 | $3.72 |
| 4. | Bullfrog AI Holdings, Inc. | $0.99 | — | $18.34 M | — | -308.69% | -1.83% | $2.04 / $0.43 | $0.19 |
| 5. | Carlsmed, Inc. | $10.94 | — | $293.52 M | — | -26.39% | -47.62% | $17.19 / $8.5 | $3.72 |
| 6. | Doximity, Inc. | $24.39 | 19.07 | $4.56 B | — | 20.77% | 23.82% | $76.51 / $20.55 | $5.29 |
| 7. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
Quarterly Results
Figures shown in M / B
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|---|
| Sales | 835.95 M | 811.24 M | 789.08 M | 759.04 M | 720.89 M | — |
| Operating Profit | 245.88 M | 240.85 M | 195.91 M | 233.73 M | 188.42 M | — |
| Net Profit | 244.2 M | 236.2 M | 200.31 M | 228.19 M | 195.62 M | — |
| EPS in Rs | 1.5 | 1.45 | 1.23 | 1.4 | 1.2 | — |
Profit & Loss
Figures shown in M / B
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Sales | 3.2 B | 2.75 B | 2.36 B | 2.16 B |
| Operating Profit | 916.37 M | 691.43 M | 429.33 M | 459.09 M |
| Net Profit | 908.91 M | 714.14 M | 525.71 M | 487.71 M |
| EPS in Rs | 5.56 | 4.37 | 3.22 | 2.99 |
Balance Sheet
Figures shown in M / B
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Total Assets | 8.98 B | 7.34 B | 5.91 B | 4.8 B |
| Total Liabilities | 1.76 B | 1.51 B | 1.27 B | 1.09 B |
| Equity | 7.21 B | 5.83 B | 4.64 B | 3.72 B |
| Current Assets | 8 B | 6.31 B | 5 B | 3.97 B |
| Current Liabilities | 1.64 B | 1.4 B | 1.18 B | 1.01 B |
Cash Flow
Last available yearly cash flow history
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Operating CF | 1.42 B | 1.09 B | 911.34 M | 780.47 M |
| Investing CF | -1.1 B | -700.14 M | -1.08 B | -1.01 B |
| Financing CF | -9.33 M | 26.11 M | -16.19 M | -19.38 M |
| Free CF | 1.42 B | 1.09 B | 911.34 M | 780.47 M |
| Capex | — | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 16.2% | 9.68% | — | — |
| Earnings Growth % | 35.84% | 7.79% | — | — |
| Profit Margin % | 26% | 22.24% | 22.63% | — |
| Operating Margin % | 25.17% | 18.16% | 21.3% | — |
| Gross Margin % | 74.53% | 71.35% | 71.72% | — |
| EBITDA Margin % | 26.61% | 19.54% | 22.65% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.